OHSU Knight Cancer Network Symposium
About the symposium
Learn about recent advances in cancer care, research and programs at OHSU and across the Knight Cancer Network in an engaging and interactive environment at this annual symposium. Join us in person at the Knight Cancer Research Building in Portland or via Webex.
Who should attend
This event is designed for cancer care teams and staff associated with the OHSU Knight Cancer Network. This includes but is not limited to medical oncologists, hematologists, radiation oncologists, surgeons, advance practice providers, researchers, administrators, clinical leaders, and staff.
Continuing Medical Education (CME)
Oregon Health & Science University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
OHSU School of Medicine designates this live activity for a maximum 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Agenda & Disclosures
For questions about this event, please email our team at email@example.com
Click the links below to view presentations from the 2023 Knight Cancer Network Symposium in PDF format:
Welcome & Knight Cancer Institute Highlights and Vision - A snapshot of the Knight Cancer Institute
Jackie Shannon, PhD
Flavio Rocha, MD, FACS, FSSO
Peritoneal Surface Malignancy - Relaunching OHSU's HIPEC Program
Divya Sood, MD
Enhancing Multi-disciplinary Care of Muscle Invasive Bladder Cancer Patients
Jen-Jane Liu, MD
Ovarian Cancer in the Era of Precision Medicine: Update 2023
Tanja Pejovic, MD, PhD
HCT & CAR T Cell Therapy The Rise of Interventional Cellular Immunology
Richard Maziarz, MD
Clinical Trials in the Community: The Power of Partnerships
Tiffani Howard, PhD
Community Partnership Program Funded Projects: Building a Community System of Care for Breast Cancer Patients Across Oregon
Pink Lemonade Project Community Resources Sheet
Susan Stearns, MBA, MA
Community Partnership Program Funded Projects: Asian Diet and Cancer
Holden Leung, MSW
Gemma Kim, MSW, LCSW, RN
ctDNA, Ready for Clinical Practice
Adel Kardosh, MD, PhD
SBRT for Prostate Cancer
Casey Williamson, MD, MAS
Click the links below to view presentations from the 2022 Knight Cancer Network Symposium in PDF format:
Prostate Cancer Clinical Genomics
Alexandra Sokolova, M.D.
Advances in Sarcoma: Focus on Clinical Trials
Lara Davis, M.D.
Cervical Cancer Inequities and Latina Women: Moving Beyond Surviving to Thriving
C. Estela Vasquez Guzman, Ph.D.
Cancer Care: The Rapidly Emerging World of Clinical Cellular Immunooncology and How it Can Integrate with Community Practices
Richard Maziarz, M.D.
Updates in Surgical Oncology: Colorectal Cancer
Flavio Rocha, M.D., F.A.C.S., F.S.S.O.
Colorectal Cancer: A Minimalist Approach
Sandy Fang, M.D., F.A.C.S., F.A.S.C.R.S.
Farm Share Rx Produce Prescription in the mid-Willamette Valley
Jared Hibbard-Swanson, Ph.D., Farm Share Rx
Wellness Education for Cancer Nutrition Study Results Final Report
Stephanie Polizzi, M.P.H., R.D., DipACLM WE CAN
Gen S: The Next Generation of Cancer Survivorship Standards
Andrea Lehman, M.S.W., L.C.S.W., O.S.W.-C.
Multi-cancer Early Detection in 2022
Tom Beer, M.D., F.A.C.P.
Bay Area Hospital and OHSU Knight Cancer Network Manuscript Review: Implementing Low-dose Computed Tomography Lung Cancer Screening in a Rural Community Hospital
Jessica Currier, Ph.D.
Click the links below to view presentations from the 2021 Knight Cancer Network Symposium in PDF format:
Knight Cancer Institute Highlights and Vision for the Future
Shivaani Kummar, M.D., F.A.C.P.
Understanding Interval Breast Cancers that are Missed by Mammogram Screening
Zhenzhen Zhang, Ph.D., M.P.H., M.Med
OHSU: Comprehensive Center of Excellence in Lymphatic Disease
Allison Nauta, M.D.
Radiotherapeutic Management of the Axilla in Breast Cancer
Kiri Cook, M.D.
Process Improvement: Assessing Your Risk and Tools for Taking Action
Adjunctive Hepatic Arterial Infusion to Convert Patients with Unresectable Liver Cancer to a Resectable Status
Skye Mayo, M.D., M.P.H., F.A.C.S.
GI Oncology- Meet the Experts and Q&A
Adel Kardosh, M.D., Ph.D.
The Cancer Committee Meeting – How to Create a High Quality, Dynamic Forum
V Liana Tsikitis, M.D., M.B.A., M.C.R.
Melissa Alvarado, M.P.H., C.T.R.
Brachytherapy for Prostate and Gynecologic Cancers: Moving the Needle
Jenna Kahn, M.D
OHSU Pancreatic Cancer Early Detection Surveillance Clinic and the PRECEDE Study
Brett Sheppard, M.D.
Aaron Grossberg, M.D., Ph.D.
Advocacy and Quality Improvement in Pancreatobiliary Cancer
Flavio Rocha, M.D.